Log In
BCIQ
Print this Print this
 

Liver cell therapy (Heparesc)

Also known as: Human heterologous liver cells

  Manage Alerts
Collapse Summary General Information
Company Promethera Biosciences S.A.
DescriptionHuman heterologous liver cells
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentRegistration
Standard IndicationUrea cycle disorder (UCD)
Indication DetailsTreat ornithine-transcarbamylase deficiency; Treat urea cycle disorders (UCD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/18/2016

Undisclosed

0

0

Get a free BioCentury trial today